- Home
- COKE vs BMRN Comparison
COKE vs BMRN Comparison
Compare COKE & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COKE
- BMRN
- Stock Information
- Founded
- COKE 1902
- BMRN 1996
- Country
- COKE United States
- BMRN United States
- Employees
- COKE N/A
- BMRN N/A
- Industry
- COKE Beverages (Production/Distribution)
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- COKE Consumer Staples
- BMRN Health Care
- Exchange
- COKE Nasdaq
- BMRN Nasdaq
- Market Cap
- COKE 10.0B
- BMRN 10.5B
- IPO Year
- COKE N/A
- BMRN 1999
- Fundamental
- Price
- COKE $164.54
- BMRN $52.76
- Analyst Decision
- COKE
- BMRN Buy
- Analyst Count
- COKE 0
- BMRN 18
- Target Price
- COKE N/A
- BMRN $90.00
- AVG Volume (30 Days)
- COKE 486.1K
- BMRN 2.8M
- Earning Date
- COKE 10-29-2025
- BMRN 10-27-2025
- Dividend Yield
- COKE 0.61%
- BMRN N/A
- EPS Growth
- COKE 22.14
- BMRN 59.53
- EPS
- COKE 7.03
- BMRN 2.68
- Revenue
- COKE $7,070,308,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- COKE N/A
- BMRN $13.32
- Revenue Next Year
- COKE N/A
- BMRN $7.51
- P/E Ratio
- COKE $23.28
- BMRN $19.58
- Revenue Growth
- COKE 4.22
- BMRN 12.39
- 52 Week Low
- COKE $105.21
- BMRN $50.76
- 52 Week High
- COKE $166.21
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- COKE 85.38
- BMRN 45.66
- Support Level
- COKE $157.11
- BMRN $51.99
- Resistance Level
- COKE $162.43
- BMRN $55.34
- Average True Range (ATR)
- COKE 4.74
- BMRN 1.43
- MACD
- COKE 2.09
- BMRN 0.04
- Stochastic Oscillator
- COKE 96.09
- BMRN 42.58
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.